Handbook of Current and Novel Protocols for the Treatment of Infertility

Handbook of Current and Novel Protocols for the Treatment of Infertility

Dahan, Michael H.; Garcia-Velasco, Juan A.; Fatemi, Human M.; Polyzos, Nikolaos P.

Elsevier Science & Technology

09/2023

464

Mole

Inglês

9780323856874

15 a 20 dias

Descrição não disponível.
1. Female evaluation
2. Male evaluation
3. Sperm DNA fragmentation
4. Ovarian stimulation and insemination
5. Ferility Care of the PCOS patient
6. The GnRh Antagonist Protocol
7. GnRh agonist trigger with or without modified Luteal phase support
8. Mild stimulation
9. The Long GnRH Agoinst protocol
10. The Microdose Flair protocol
11. Random start IVF
12. Dual stim
13. Progestin-primed ovarian stimulation
14. Introduction to the IVF laboratory
15. Stimulated IVM
16. Unstimulated IVM
17. Introduction to the IVM laboratory
18. Fertility preservation
19. Time lapse imaging
20. Artificail Intelligence in ART
21. PGT-A
22. PGT-D
23. Maximizing outcome in poor responders
24. How to fix Repetitive IVF Failures
25. Nutritional supplements in fertility care
26. The vaginal Biome
27. Endometrial Receptivity
28. The role of surgery in infertility
29. Management of Ovarian Hyper-Stimulation Syndrome
30. Complication of IVF that are not OHSS and their management
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Accreditation; Adjuvants; Advance maternal age; AGE banking; Age related decline; Air quality; Andrology; Aneuploidies; Antibiotic; ART; Artificial intelligence; Aspirin; Assisted reproductive technology (ART)Complications of in vitro fertilization (IVF)Egg retrieval complications; Assisted reproductive technology; Automation; Biopsy; Blastocyst; Chronic endometritis; Cleanroom construction; Clinical outcomes; Clomiphene citrate; Clomiphene; Comprehensive chromosome testing; Congenital bilateral absence of the vas deferens (CBAVD)Cryptozoospermia; CoQ10DHEA; Cryopreservation; Culture system; Cumulative pregnancy outcome; Cycle cancellation; Diagnostic; Donor insemination; Dopamine agonists; Double stimulation in one ovarian cycle; Double trigger; Dual trigger; DuoStim; Dysbiosis; Early- onset and late on-set OHSS; Early pregnancy loss; Embryo implantation; Endometrial polyps; Endometrial receptivity; Endometrium; Failure modes and effects analysis; Fecundity; Female; Fertility preservation; Fibroids; FSH stimulation; FSH; Glucocorticoids; GnRH agonist; GnRH analogs; GnRH antagonist; Gonadal tissue; Gonadotropin; Gonadotropins; Growth hormone; hCG (human chorionic gonadotrophin)PCOS; hCG; Hemoperitoneum; High responders; Hysterosalpingogram; Immature oocyte; Immunomodulation; Implantation; In vitro fertilization (IVF)In vitro maturation (IVM)Infertility; In vitro fertilization laboratory; In vitro fertilization; In vitro maturation; Infertility; Inositol; Inositols; Insemination cancellation; Intrauterine adhesions; Intrauterine insemination; IVF; IVM; Key performance indicators; Laboratory setup; Laboratory; Laparoscopic ovarian drilling; Letrozole; LH; Live birth rate; Long protocol; Luteal phase support; Male infertility; Medical history; Metformin; Microbiome; Mild ovarian stimulation; Miscarriage; Monogenic conditions; Morphokinetics; Natural cycle; Non-invasive; Nonobstructive azoospermia; Nonvisualized pregnancy loss; Obstructive azoospermia; Oligospermia; Oncology; Oocyte competency; Oocyte maturation process; Oocyte maturation; Oocyte pick up; Oocyte quality; Oocyte; Organ injury; Ovarian cortex; Ovarian hyperstimulation syndrome; Ovarian stimulation; Ovarian torsion; Ovulation inhibition; Ovulation trigger; Ovulation; PCOS; Pelvic infection; Personalized embryo transfer; PGT; PGT-A; pH; Planned oocyte cryopreservation; Polycystic ovarian syndrome (PCOS)Poor ovarian response; Poor prognosis patients; Poor responders; Pregnancy; Preimplantation genetic testing; Preimplantation; Probiotic; Process control; Process mapping; Progestin-primed ovarian stimulation; Progestins; Proximal tubal obstruction; Psychological morbidity; Quality control; Quality management; Quality; Recurrent implantation failure; Recurrent pregnancy loss; Repetitive implantation failure; Risk management; Root cause analysis; SDF tests; Semen analysis; Sperm chromatin; Sperm DNA fragmentation; Sperm; Standard IVM; Structural rearrangements; Temperature; Testosterone; Therapeutic; Time-lapse; Transgender; Troubleshooting; Unexplained recurrent pregnancy loss; Uterine septum; VEGF (vascular endothelial growth factor)Vitamin D; Vitrification; Window of implantation